NCT06741644 A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05700448 Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE3
NCT05381753 Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World Status COMPLETED Phase N/A
NCT05297890 A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05279300 A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas Status RECRUITING Phase PHASE1
NCT04472858 A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT04421352 Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients Status COMPLETED Phase PHASE1
NCT04338724 A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04254939 A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor Status COMPLETED Phase PHASE1/PHASE2
NCT04200404 A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04194801 A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT04194775 A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04187352 A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE3
NCT04176393 A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation Status COMPLETED Phase PHASE1
NCT03809767 A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT03802591 A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma Status COMPLETED Phase PHASE3
NCT03789604 A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3